Email updates

Keep up to date with the latest news and content from BMC Clinical Pathology and BioMed Central.

Open Access Research article

Ki-67 is a strong prognostic marker of non-small cell lung cancer when tissue heterogeneity is considered

Kazuhiro Tabata12, Tomonori Tanaka12, Tomayoshi Hayashi2, Takashi Hori34, Sayuri Nunomura12, Suguru Yonezawa5 and Junya Fukuoka12*

Author Affiliations

1 Department of Pathology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

2 Department of Pathology, Nagasaki University Hospital, Nagasaki, Japan

3 Department of Surgical Pathology, Laboratory of Pathology, Toyama, Japan

4 Department of Pathology, Toyama University Hospital, 2630 Sugitani, Toyama 930-0194, Japan

5 Department of Human Pathology, Field of Oncology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan

For all author emails, please log on.

BMC Clinical Pathology 2014, 14:23  doi:10.1186/1472-6890-14-23

Published: 13 May 2014

Abstract

Background

Ki-67 expression is a well-established prognostic marker in various cancers. However, Ki-67 expression is also known as being heterogeneous. We investigated the prognostic significance of Ki-67 from the view of staining heterogeneity by the technique of Spiral Array.

Methods

100 cases of resected lung cancer from Toyama university hospital archive were collected. Spiral Array blocks were generated out of 100 cases using 100 μm thick paraffin sections. Four μm thick sections of the Array block were stained for Ki-67. Staining results in each reel were scored for areas with lowest (LS), highest (HS), and average (AS) expression, exclusively in the cancer cells. Heterogeneity score (HeS) was designed as the difference between HS and LS. The scores were divided into four grades (0–3). Clinical information was collected, and the prognostic significance of Ki-67 was analyzed.

Results

Pathological stage was available for 91 patients (43 stage IA, 22 stage IB, 2 stage IIA, 9 stage IIB, 13 stage IIIA, 1 stage IIIB, and 1 stage IV). The HS of Ki-67 score in non-small cell lung cancer was 3 in 17 cases, 2 in 27 cases, 1 in 28 cases, 0 in 21 cases, and 4 reels were lost. 78 cases had clinical follow up. 74 cases had all the information available and were analyzed for correlation between Ki-67 expression and survival. Cases with score 2 and 3 of HS and HeS showed significant poorer prognosis (both P < 0.001), whereas LS or AS did not show significance. The results were identical when analyzing adenocarcinoma and squamous cell carcinoma, separately. Cox multivariate analysis of Ki-67 showed that HS was an independent risk factor affecting overall survival.

Conclusions

Ki-67 is a strong prognostic marker for non-small cell lung cancer when the degree of highest staining frequency or heterogeneity is considered.

Keywords:
Tissue microarray; Tissue heterogeneity; Expression; Biomarkers; Pathology; Lung cancer